Latest Insider Transactions at Personalis, Inc. (PSNL)
This section provides a real-time view of insider transactions for Personalis, Inc. (PSNL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Personalis, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Personalis, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Aaron Tachibana CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+23.52%
|
-
|
|
Dec 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,184
-2.27%
|
$50,208
$12.92 P/Share
|
|
Dec 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
419
-0.52%
|
$5,028
$12.92 P/Share
|
|
Nov 30
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-17.08%
|
$1,300,000
$13.65 P/Share
|
|
Nov 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,253
-1.55%
|
$21,301
$17.04 P/Share
|
|
Nov 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,253
-0.68%
|
$21,301
$17.04 P/Share
|
|
Nov 17
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
2,348
-0.4%
|
$39,916
$17.04 P/Share
|
|
Oct 29
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
711
+0.88%
|
$11,376
$16.68 P/Share
|
|
Oct 12
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-14.54%
|
$1,900,000
$19.33 P/Share
|
|
Sep 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,088
-1.32%
|
$22,848
$21.25 P/Share
|
|
Sep 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,152
-1.67%
|
$66,192
$21.25 P/Share
|
|
Sep 14
2021
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-6.4%
|
$2,100,000
$21.97 P/Share
|
|
Sep 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
291
-0.35%
|
$6,111
$21.92 P/Share
|
|
Sep 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,820
-1.98%
|
$80,220
$21.92 P/Share
|
|
Aug 26
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
77,272
+8.93%
|
$0
$0.44 P/Share
|
|
Aug 19
2021
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
115,228
-13.95%
|
$1,843,648
$16.81 P/Share
|
|
Aug 19
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,228
+12.25%
|
$0
$0.44 P/Share
|
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
4,436
-5.11%
|
$93,156
$21.22 P/Share
|
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Exercise of conversion of derivative security
|
Direct |
15,564
-15.2%
|
$326,844
$21.18 P/Share
|
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
15,564
+13.19%
|
-
|
|
Jul 27
2021
|
Aaron Tachibana CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+4.94%
|
-
|
|
Jul 27
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.53%
|
-
|
|
Jul 15
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+9.55%
|
$0
$0.44 P/Share
|
|
Jul 08
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
110,000
-14.75%
|
$2,420,000
$22.54 P/Share
|
|
Jul 08
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+12.86%
|
$0
$0.44 P/Share
|
|
Jun 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,101
-1.45%
|
$24,222
$22.75 P/Share
|
|
Jun 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,421
-1.31%
|
$53,262
$22.75 P/Share
|
|
Jun 15
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+10.56%
|
$0
$0.44 P/Share
|
|
Jun 08
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
110,000
-8.33%
|
$2,420,000
$22.66 P/Share
|
|
Jun 08
2021
|
John Stephen West President and CEO |
SELL
Grant, award, or other acquisition
|
Direct |
110,000
-14.09%
|
$0
$0.44 P/Share
|
|
Jun 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
291
-0.38%
|
$6,111
$21.57 P/Share
|
|
Jun 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,899
-1.54%
|
$60,879
$21.57 P/Share
|
|
May 15
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,750
+8.75%
|
-
|
|
May 15
2021
|
Aaron Tachibana CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+9.62%
|
-
|
|
May 15
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.75%
|
-
|
|
May 14
2021
|
A Blaine Bowman |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+50.0%
|
-
|
|
May 14
2021
|
Alan Colowick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+50.0%
|
-
|
|
May 14
2021
|
Ken Ludlum Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+7.71%
|
-
|
|
May 14
2021
|
Jonathan Mac Quitty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+50.0%
|
-
|
|
May 14
2021
|
Karin Eastham |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+50.0%
|
-
|
|
May 14
2021
|
Woodrow A Myers Jr |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+33.85%
|
-
|
|
Apr 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
40,000
-17.96%
|
$1,000,000
$25.75 P/Share
|
|
Apr 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
12,517
+15.48%
|
$0
$0.44 P/Share
|
|
Mar 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,446
-1.44%
|
$63,596
$26.73 P/Share
|
|
Mar 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,130
-1.34%
|
$29,380
$26.73 P/Share
|
|
Mar 06
2021
|
Woodrow A Myers Jr |
BUY
Grant, award, or other acquisition
|
Direct |
2,610
+50.0%
|
-
|
|
Mar 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
345
-0.41%
|
$11,040
$32.6 P/Share
|
|
Mar 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,022
-1.74%
|
$96,704
$32.6 P/Share
|
|
Feb 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
40,000
-9.73%
|
$1,520,000
$38.49 P/Share
|
|
Feb 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
13,422
+12.02%
|
$0
$0.44 P/Share
|